Effects of low doses of estrone on the proliferation, differentiation and mineralization of osteoprecursor cells

Park,Jun-Beom

doi:10.3892/etm.2012.655

Effects of low doses of estrone on the proliferation, differentiation and mineralization of osteoprecursor cells

Authors:
- Jun-Beom Park
View Affiliations

Affiliations: Department of Periodontics, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul 137-701, Republic of Korea
Published online on: August 3, 2012 https://doi.org/10.3892/etm.2012.655
Pages: 681-684

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The purpose of this study was to evaluate the effects of low doses of estrone on the proliferation, differentiation and mineralization of osteoprecursor cells. The effect on cell viability was determined using a 3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide (MTT) assay, whereas differentiation and mineralization were examined using an alkaline phosphatase activity test and alizarin red S staining, respectively. The protein expression of estrogen receptor-α (ER‑α), estrogen receptor-β (ER‑β) and osteopontin (OPN) is assosciated with bone formation. Cell cultures grown in the presence of estrone at concentrations of 0.1 and 1 nM demonstrated an increase in relative values in the MTT assay and cells grown in the presence of estrone at the 10 nM concentration demonstrated an increase in mineralization. The results of the western blot analysis indicated that the addition of estrone upregulated ER‑α and ER‑β expression, but downregulated the expression of OPN. Based on these findings, it was hypothesized that a low dose of estrone produces positive effects on the mineralization of osteoprecursor cells. Moreover, these results also suggested that higher doses of estrone may be required to significantly enhance the differentiation and mineralization.

View Figures

View References

1	Dechering K, Boersma C and Mosselman S: Estrogen receptors alpha and beta: two receptors of a kind? Curr Med Chem. 7:561–576. 2000. View Article : Google Scholar : PubMed/NCBI
2	Syed F and Khosla S: Mechanisms of sex steroid effects on bone. Biochem Biophys Res Commun. 328:688–696. 2005. View Article : Google Scholar : PubMed/NCBI
3	Wang Y, Li LZ, Zhang YL, Zhu YQ, Wu J and Sun WJ: LC, a novel estrone-rhein hybrid compound, concurrently stimulates osteoprotegerin and inhibits receptor activator of NF-kappaB ligand (RANKL) and interleukin-6 production by human osteoblastic cells. Mol Cell Endocrinol. 337:43–51. 2011. View Article : Google Scholar
4	López-Marcos JF, García-Valle S and García-Iglesias AA: Periodontal aspects in menopausal women undergoing hormone replacement therapy. Med Oral Patol Oral Cir Bucal. 10:132–141. 2005.(In English and Spanish).
5	Tarakji B, Nassani MZ and Sloan P: Immunohistochemical expression of estrogens and progesterone receptors in carcinoma ex pleomorphic adenoma-undifferentiated and adenocarcinoma types. Med Oral Patol Oral Cir Bucal. 15:e432–e436. 2010. View Article : Google Scholar
6	Coelingh Bennink HJ: Are all estrogens the same? Maturitas. 47:269–275. 2004.PubMed/NCBI
7	Qu Q, Perälä-Heape M, Kapanen A, et al: Estrogen enhances differentiation of osteoblasts in mouse bone marrow culture. Bone. 22:201–209. 1998. View Article : Google Scholar : PubMed/NCBI
8	Wang Y, Li LZ, Zhang YL, et al: LC, a novel estrone-rhein hybrid compound, promotes proliferation and differentiation and protects against cell death in human osteoblastic MG-63 cells. Mol Cell Endocrinol. 344:59–68. 2011. View Article : Google Scholar
9	Park JB: Effects of fibroblast growth factor 2 on osteoblastic proliferation and differentiation by regulating bone morphogenetic protein receptor expression. J Craniofac Surg. 22:1880–1882. 2011. View Article : Google Scholar
10	Odabaş ME, Ertürk M, Çinar Ç, Tuzüner T and Tulunoğlu Ö: Cytotoxicity of a new hemostatic agent on human pulp fibroblasts in vitro. Med Oral Patol Oral Cir Bucal. 16:e584–e587. 2011.PubMed/NCBI
11	Luo XH and Liao EY: Effects of estriol on the proliferation and differentiation of human osteoblastic MG-63 cells. Endocr Res. 29:343–351. 2003. View Article : Google Scholar : PubMed/NCBI
12	Park JB: The effects of dexamethasone, ascorbic acid, and beta-glycerophosphate on osteoblastic differentiation by regulating estrogen receptor and osteopontin expression. J Surg Res. 173:99–104. 2012. View Article : Google Scholar : PubMed/NCBI
13	Todorovic T, Dozic I, Vicente-Barrero M, et al: Salivary enzymes and periodontal disease. Med Oral Patol Oral Cir Bucal. 11:E115–E119. 2006.(In Spanish and English).
14	Fernández-Tresguerres-Hernández-Gil I, Alobera-Gracia MA, del-Canto-Pingarrón M and Blanco-Jerez L: Physiological bases of bone regeneration. I. Histology and physiology of bone tissue. Med Oral Patol Oral Cir Bucal. 11:E47–E51. 2006.(In English and Spanish).
15	Park JB: Effects of doxycycline, minocycline, and tetracycline on cell proliferation, differentiation, and protein expression in osteoprecursor cells. J Craniofac Surg. 22:1839–1842. 2011. View Article : Google Scholar : PubMed/NCBI
16	Pinzone JJ, Stevenson H, Strobl JS and Berg PE: Molecular and cellular determinants of estrogen receptor alpha expression. Mol Cell Biol. 24:4605–4612. 2004. View Article : Google Scholar : PubMed/NCBI
17	Huang W, Carlsen B, Rudkin G, et al: Osteopontin is a negative regulator of proliferation and differentiation in MC3T3-E1 preosteoblastic cells. Bone. 34:799–808. 2004. View Article : Google Scholar : PubMed/NCBI